[CYCC] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
16-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- 47.16%
YoY- 45.14%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 264 212 5 38 146 161 175 31.56%
PBT 1,248 -3,356 -5,067 -3,572 -3,704 -3,123 -3,780 -
Tax -230 -258 -637 -419 -127 -168 -122 52.66%
NP 1,429 -3,082 -4,764 -1,890 -3,577 -2,955 -3,658 -
Tax Rate 18.43% - - - - - - -
Total Cost -1,165 3,294 4,769 1,928 3,723 3,116 3,833 -
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 541.29 -1,453.77 -95,280.00 -4,973.68 -2,450.00 -1,835.40 -2,090.29 -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS 24.00 -75.55 -149.01 -53.81 -101.86 -90.66 -113.25 -
EPS Diluted 24.00 -75.55 -149.01 -53.81 -101.86 -90.66 -112.22 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.